HAG
HighPoint Advisor Group’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Buy |
1,244
+33
| +3% | +$7.22K | 0.01% | 553 |
|
|
2025
Q1 | $259K | Sell |
1,211
-308
| -20% | -$65.7K | 0.02% | 532 |
|
|
2024
Q4 | $490K | Buy |
1,519
+55
| +4% | +$17.7K | 0.03% | 385 |
|
|
2024
Q3 | $463K | Sell |
1,464
-23
| -2% | -$7.28K | 0.03% | 372 |
|
|
2024
Q2 | $445K | Sell |
1,487
-938
| -39% | -$281K | 0.03% | 381 |
|
|
2024
Q1 | $869K | Buy |
2,425
+50
| +2% | +$17.9K | 0.06% | 239 |
|
|
2023
Q4 | $922K | Buy |
+2,375
| New | +$922K | 0.07% | 230 |
|
|
2022
Q2 | $726K | Buy |
+2,300
| New | +$726K | 0.08% | 201 |
|
|
2021
Q3 | $407K | Buy |
+959
| New | +$407K | 0.04% | 345 |
|
|
2020
Q4 | – | Sell |
-1,229
| Closed | -$363K | – | 508 |
|
|
2020
Q3 | $363K | Sell |
1,229
-44
| -3% | -$13K | 0.07% | 236 |
|
|
2020
Q2 | $286K | Buy |
+1,273
| New | +$286K | 0.06% | 253 |
|
|
2019
Q4 | – | Sell |
-876
| Closed | -$129K | – | 478 |
|
|
2019
Q3 | $129K | Sell |
876
-162
| -16% | -$23.9K | 0.03% | 411 |
|
|
2019
Q2 | $127K | Buy |
+1,038
| New | +$127K | 0.03% | 398 |
|